What: Amid growing interest in testosterone for treating various menopausal symptoms—from mood improvement to increased libido—experts urge caution.
Key line: [Details not provided].
Source: New York Times.
A New York physician faces indictment in Louisiana for prescribing abortion pills.
The Trump IVF Executive Order does not make IVF free but instead asks for policy recommendations to lower costs, marking an initial step.
Exclusive subscriber content: a comprehensive report on upcoming shifts in women’s health and a 2024 stories database.
A marijuana business trade publication reports that some producers are eyeing cannabis-based treatments for women’s health issues.
A study comparing sisters of women with and without pregnancy complications found that genetic and environmental factors may drive cardiovascular disease risk.
Chiquita Brooks-LaSure warns that cuts by Elon Musk’s DOGE team could jeopardize health insurance coverage for many American women, affecting both Medicaid and Medicare.
A randomized control trial found that postpartum women treated with nifedipine had a dramatically lower readmission rate than those on labetalol.
Emerging discussions about what happens after stopping hormonal birth control spark debate.
A study finds that postmenopausal women are significantly more at risk for long COVID compared to men.
Halle Berry speaks with Time about her plans to push for improved menopause treatment and increased emphasis on menopause education in medical schools.
A JAMA study finds that in states with abortion bans, a modest increase in fertility is accompanied by a significant rise in infant mortality rates.
The Trump administration’s removal of CDC pages is disrupting detailed contraceptive guidelines.
An Associated Press overview details how various states are introducing bills to criminalize women for obtaining abortion pills.
Cosmo UK explores the phenomenon dubbed ‘post‐birth control syndrome’ despite its unofficial status.
A report highlights confusion over Tennessee’s recent Medicaid expansion for postpartum care.
The 19th reports on the legal battles facing Dr. Margaret Carpenter over providing abortion pills, with questions about extradition and state protections.
An analysis of five years of U.S. maternal mortality data reveals significant state-to-state differences in causes of death.
The debate over rebranding early-stage cancers like DCIS aims to reduce patient anxiety.
Amid administrative chaos, the NIH acting director assured that key research projects would proceed.
A review of over 90,000 drug trials shows that pregnant women are almost entirely excluded.